Microorganisms such as bacteria, fungi, and blue-green algae have proven to be a rich source of new biologically active secondary metabolites. 1 Marine microorganisms, particularly marine fungi, have recently drawn much attention as an important source of biologically active secondary metabolites. 2 Among marine fungi, those living in association with marine algae are promising sources of novel natural products due to their unique ecological niche. The association between algae and fungi appears to be highly developed since nearly one-third of all higher marine fungi described are namely algicolous or algae-associated organisms. 3 Recently, marine-derived fungi have yielded unique biologically active metabolites, such as myrothenones, 4 gliotoxin derivatives, 5 and asperflavin ribofuranoside, 6 suggesting that these organisms would be valuable producers of potential therapeutic agents.
As part of our search for bioactive substances from marine microorganism, 6 the fungus was studied because the broth extract showed potent tyrosinase inhibitory activity. 7 In order to identify the active compounds, the broth was further separated into single ones. Careful bioassay-guided fractionations resulted in isolation of a new α-pyrone derivative, 6-[(E)-hept-1-enyl]-α-pyrone (1), and two known compounds, 6-[(E)-pent-1-enyl]-α-pyrone (2) 8 and 4-hydroxyphenethyl alcohol (3) 9 from the marine isolate of fungus Botrytis sp. We herein report the isolation and structural elucidation of compounds 1-3. ), respectively. The connection of functional groups in 1 was achieved on the basis of HMBC. Diagnostic HMBC correlations, from H-5 to C-1', from H-1' to C-5, C-6 and C-3', and from H-2' to C-6, C-3' and C-4', showed the connection of C6-C1' in 1. The coupling constant between H-1' and H-2' (J H1'-H2' = 15.5 Hz) was critical in establishing the (E) geometry of double bond of compound 1. On the basis of all the foregoing evidence, we propose that the structure of compound 1 is 6-[(E)-hept-1-enyl]-α-pyrone.
The known compounds 2 and 3 were identified by spectroscopic analysis (   1   H and   13 C NMR, and LREIMS) and comparison to literature data. 8, 9 Compound 1 exhibited a tyrosinase inhibitory activity with IC 50 value of 4.5 μM, which is more active than kojic acid (IC 50 , 15.5 μM) currently being used as a functional personal-care compound. But compound 2 showed a weak tyrosinase inhibitory activity with IC 50 value of 155.5 μM.
Experimental Section
General. UV/visible spectra were measured on a Hitachi U-2001 UV/Vis spectrometer. IR spectra were recorded on a Bruker FT-IR model IFS-88 spectrometer. Extraction and Isolation. The mycelium and broth were separated by filtration. The filtered broth was extracted with EtOAc to afford broth extract (0.9 g), which was subjected to Si gel flash chromatography. Elution was performed with n-hexane-EtOAc (stepwise, 0-100% EtOAc) to yield four fractions. Fractions 2 and 3 on medium pressure liquid chromatography (MPLC) (ODS) by elution with H 2 OMeOH (from 1:1 to 1:5) afforded crude compounds 1 and 2, and 3, respectively, which were further purified by HPLC (YMC, ODS-A) utilizing a 30 min gradient program of 50% to 100% MeOH in H 2 O to furnish 1 (10.2 mg), 2 (1.5 mg), and 3 (3.5 mg), respectively. (2) and 4-hydroxyphenethyl alcohol (3) were obtained as a colorless oil, and showed spectral data virtually identical to those reported in the literature. 8, 9 
